InventisBio Co., Limited reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 8.61 million. Net loss was CNY 83.18 million compared to CNY 117.87 million a year ago.

Basic loss per share from continuing operations was CNY 0.14 compared to CNY 0.2 a year ago. Diluted loss per share from continuing operations was CNY 0.14 compared to CNY 0.2 a year ago.